Quote:

---

If the CD12 numbers aren't what we hope for, no other country is going to jump for leronlimab, or they ALREADY WOULD HAVE.

Read More: https://investorshangout.com/post/view?id=602...z6kE51Lm5r

---

I couldnt disagree more. Obviously if we flop completely no one will be interested, but we have a pretty high degree of confidence that will not be the case.

However, a more likely scenario is that we reduce mortality by a figure that doesn't quite get us a p value of <.05. Based on some of the statistical analysis done here and elsewhere, a reduction of 25% would fit this scenario.

Do you really think that if we reduce mortality by 25%, but have a p value of .06, that we wont get EUA somewhere? I find that extraordinarily unlikely.